An Implantable Device for Type 1 Diabetes Treatment
Engineering of a novel device to treat T1D, featuring local immunosuppression and a vascularized cell reservoir to prolong islet cell survival. (Source: The Scientist)
Source: The Scientist - April 18, 2023 Category: Science Tags: Sponsored Article Source Type: news
MyType1 Diabetes online support
MyType1 Diabetes is a free online resource to help adults in England live well with their type 1 diabetes. (Source: NHS Networks)
Source: NHS Networks - April 17, 2023 Category: UK Health Source Type: news
Why Did Type 1 Diabetes Rise Early in the COVID-19 Pandemic? Why Did Type 1 Diabetes Rise Early in the COVID-19 Pandemic?
Finnish investigators suggest that both increased incidence and severity at diagnosis could be related to pandemic lockdown measures rather than the SARS-CoV-2 virus itself, but other experts aren ' t sure.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 5, 2023 Category: Allergy & Immunology Tags: Diabetes & Endocrinology News Source Type: news
Are we proof that a new drug to stop diseases like arthritis and type 1 diabetes really DOES work?
Mahn Singh is the first British child to be part of a trial for a new drug, teplizumab, which blocks the immune system malfunction that destroys insulin-producing cells and causes type 1 diabetes. (Source: the Mail online | Health)
Source: the Mail online | Health - April 3, 2023 Category: Consumer Health News Source Type: news
Nanoparticle with mRNA appears to prevent, treat peanut allergies in mice
Key takeawaysPeanuts are one of the most common food allergens for children.UCLA scientists have developed a nanoparticle that delivers mRNA to liver cells in order to teach the immune system to tolerate peanut protein and alleviate allergies.In mice, the nanoparticle successfully dampened symptoms of serious allergy.Peanut allergies affect 1 in 50 children, and the most severe cases lead to a potentially deadly immune reaction called anaphylactic shock.Currently, there is only one approved treatment that reduces the severity of the allergic reaction, and it takes months to kick in. A group of UCLA immunologists is aiming ...
Source: UCLA Newsroom: Health Sciences - April 3, 2023 Category: Universities & Medical Training Source Type: news
Incidence of Type 1, Type 2 Diabetes Increasing in People Younger Than 20
FRIDAY, March 31, 2023 -- The incidence of type 1 and type 2 diabetes is increasing among children and young people aged 0 to 19 years, according to a study published in the April issue of The Lancet Diabetes& Endocrinology.
Lynne E.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 31, 2023 Category: Pharmaceuticals Source Type: news
Doctors Convert Veins Into Arteries to Spare Patients Amputations
THURSDAY, March 30, 2023 -- Cynthia Elford had recently lost her left leg to type 1 diabetes, after a sunburned big toe turned nearly black and forced an amputation.
Now, Elford was being told the same thing was happening in her right leg. “I went... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 30, 2023 Category: General Medicine Source Type: news
AHA News: Explaining Cardiovascular Risk Disparities Among Young People With Type 1 Diabetes
THURSDAY, March 30, 2023 (American Heart Association News) -- Black and Hispanic children with Type 1 diabetes are more likely than their white peers to develop stiffened arteries – a precursor to heart disease and stroke – during the first... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 30, 2023 Category: General Medicine Source Type: news
A new procedure offers hope to 'no option' patients facing amputation because of severe circulation problems
Cynthia Elford loves to travel and hike, but a few years ago, her Type 1 diabetes made getting around nearly impossible. By 2018, the Pennsylvania grandmother faced the possibility of losing her right leg because of a diabetes-related circulation problem, and she developed sores on her toes that kept getting worse. (Source: CNN.com - Health)
Source: CNN.com - Health - March 29, 2023 Category: Consumer Health News Source Type: news
Artificial pancreas controls blood sugar in young children with type 1 diabetes
Children aged 2 to 5 with type 1 diabetes who received an artificial pancreas had more stable blood glucose levels than those who received standard care. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - March 27, 2023 Category: Consumer Health News Source Type: news
Could a Baby's Gut Health Be an Early Predictor of Future T1D? Could a Baby's Gut Health Be an Early Predictor of Future T1D?
The makeup of gut bacteria in those as young as aged 1 may predict future risk for developing type 1 diabetes, which could help identify those at high risk earlier.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - March 27, 2023 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
Gut bacteria in babies may predict type 1 diabetes in later life, study finds
Researchers identify ‘microbe signature’ found to be in infants who went on to develop disease in childhood or adolescenceBacteria in the gut of one-year-old infants could be used to predict their chances of developingtype 1 diabetes in later life, scientists have announced. The disease most often occurs in children and adolescents and is triggered by the body ’s immune system when it attacks and destroys insulin-making cells in the pancreas.“Our findings indicate that the gut of infants who go on to develop type 1 diabetes is notably different from healthy babies, and that several microbial biomarkers associated w...
Source: Guardian Unlimited Science - March 26, 2023 Category: Science Authors: Robin McKie Science Editor Tags: Diabetes Health Children's health Society Medical research Source Type: news
Doxorubicin and Cyclophosphamide Therapy-induced Type 1 DM Doxorubicin and Cyclophosphamide Therapy-induced Type 1 DM
The case highlights the need to be aware that doxorubicin and cyclophosphamide therapy may cause unexpected adverse responses, including type 1 diabetes.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 24, 2023 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news
